The FDA Bad Ad Program and Prescription Drug Promotion

About This Site:

This activity is supported by the U.S. Food and Drug Administration (FDA) through a contract from the U.S. Department of Health and Human Services, and FDA's privacy policies apply while you are on this site.

Continuing Education Credits (CE) Released: 07/13/2020; Valid for credit through: 07/13/2023

Credits Available:

Physicians – 1.0 AMA PRA Category 1 Credit(s)™
Nurses – 1.0 ANCC Contact Hours
Pharmacists and Pharmacy Technicians – 1.0 ACPE Contact Hours
Nurse Practitioners – 1.0 AANP Contact Hours
Physician Assistants – 1.0 hours of Category 1 Credit

Certificates of Completion:

For users wishing to have confirmation that they have completed this course, they may choose to receive a Certificate of Completion which comes with no CE credits.

Target Audience:

The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, pharmacists, and pharmacy technicians. The course can be taken for informational purposes or for Continuing Education (CE) credit.

Description:

This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation's healthcare professionals about prescription drug advertising and promotion.

Satisfactory Completion:

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, pass the post-test with a score of 70% or higher and/or complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.

NOTE: If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  • Identify the role that FDA’s Office of Prescription Drug Promotion, or OPDP, plays in regulating prescription drug promotion and advertising.
  • Recognize persuasive techniques commonly used in advertising and promotion.
  • Describe the most common regulatory issues raised by prescription drug promotion.
  • Recognize potentially false or misleading prescription drug promotion.
  • Locate the Bad Ad contact information.
  • Translate knowledge into action and report potentially problematic prescription drug promotion to OPDP.

Acknowledgement of Financial Commercial Support:

No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support:

No in-kind commercial support was received for this educational activity.

Disclosure Information

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content of CME disclosed to Amedco. All of these relationships were treated as a conflict of interest and have been resolved. (C7 SCS 6.1--6.2, 6.5).

All individuals in a position to control the content of CE/CME are listed below and had no relevant financial relationship to disclose.

First NameLast NameDisclosure
RobertDeanNothing to disclose
ElaineFrostNothing to disclose
AnkurKalolaNothing to disclose
JinaKwakNothing to disclose
HaileyLeeNothing to disclose
SophiaNiNothing to disclose
MeetaPatelNothing to disclose
ElizabethPepinskyNothing to disclose
MeenaSavaniNothing to disclose
RachelShawNothing to disclose

Handouts and Resources:

Accreditation Statement:

Jointly Accredited Provider Logo

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the U.S. Food and Drug Administration (FDA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement:

Amedco LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Credit Designation Statement:

Amedco LLC designates this enduring material for a maximum of 1 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist and Pharmacy Technician Credit Designation Statement:

Amedco LLC designates this enduring material for a maximum of 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
UAN(s): JA4008163-9999-20-054-H04-P, JA4008163-9999-20-054-H04-T

NOTE to Pharmacists and Pharmacy Technicians: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Nurse Practitioner Credit Designation Statement:

AANP Accredited Stamp

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20054263. This activity was planned in accordance with AANP Accreditation Standards and Policies.

Physician Assistant Credit Designation Statement:

American Academy of PAs Logo

Amedco has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until July 13, 2023. PAs should only claim credit commensurate with the extent of their participation.

Technical Requirements and Instructions:

To access the course, users will need a computer with an Internet connection, and:

  • Internet Explorer 10 or higher,
  • Firefox 43 or higher,
  • Safari 9 or higher, or
  • Any other W3C standards compliant browser

An HTML5 capable browser is required for video playback. Occasionally, other additional software may be required such as Microsoft PowerPoint or Adobe Acrobat Reader. Viewing on a desktop, laptop, or tablet is recommended.

To receive your certificate for CE credit, you must complete the post-test and receive a score of 80% or better and complete an evaluation form. Other users may complete evaluation and print a Certificate of Completion.

Please note that the preload and autoplay function for videos and audios is disabled for iOS devices using Safari on cellular networks, and requires a manual playback using the onscreen controls. For additional information, please refer to Apple's Safari HTML 5 Audio and Video Guide.

For questions about content or about technical issues, you may contact FDA:

Toll Free
(855) 543-3784, or
(301) 796-3400
druginfo@fda.hhs.gov